智通财经APP讯，昊海生物科技(06826)发布公告，公司于2025年6月25日披露了《上海昊海生物科技股份有限公司股东减持股份计划公告》(公告编号：2025-032)，楼国梁先生因自身资金需要，计划自该公告披露之日起3个交易日后3个月内，通过集中竞价和大宗交易方式合计减持不超过150万股的公司股份，占减持计划披露时公司总股本2.33亿股的比例不超过0.6432%，其中，通过集中竞价方式减持不超过150万股，通过大宗交易方式减持不超过150万股。减持价格将根据二级市场价格确定。
公司于2025年9月29日收到楼国梁先生出具的《关于股份减持结果的告知函》，其本次股份减持计划时间区间届满。截至2025年9月29日，楼国梁先生已通过集中竞价的方式累计减持公司股份149.14万股，占目前公司总股本2.33亿股的0.6413%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.